HENGXU Capital, a private equity investment firm operating under SAIC Motor.

Hengxu Capital was founded in 2019. As a key private equity investment institution under SAIC Financial Holdings, we aim to maximize the investor's returns of investments. Relying on the overall industrial advantages of SAIC and the efficient synergy of SAIC Financial Holdings, our team is focused on green communications, communications system, healthcare and other emerging industries, which contribute to the development of SAIC's innovative industrial chain and mobility ecosystem. Our goal is to become a leading industrial capital and trusted top-tier investment institution.

History

2019
2020
2021
2022

Hengxu Capital Establishment

Successfully raised 5 billion -scale Yangtze River Delta Fund

The first investment company Aibo Medical successful IPO

Winning investment list · China's best private equity investment institution top100

Winning China · Best Private Equity Investment Institution TOP100

The management scale exceeds 20 billion

Winning Qingke List · China Private Equity Investment Institution TOP100

The management scale exceeds 30 billion

Private equity investment fund manager selected for insurance fund investment evaluates the list of class A

Portfolios

--MORE >
北京经纬恒润科技股份有限公司
经纬恒润成立于2003年,专注于为汽车、无人运输等领域的客户提供电子产品、研发服务和高级别智能驾驶整体解决方案。
股票代码:688326.SH
https://www.hirain.com/
北京晶品特装科技股份有限公司
公司主营业务为光电侦察设备和军用机器人系统的研发、生产和销售,主要产品包括多个型号系列的无人机光电吊舱、手持光电侦察设备、单兵夜视镜、手持穿墙雷达、排爆机器人、多用途机器人、便携式侦察机器人等。
股票代码:688084.SH
https://www.jp-tz.com/
清陶(昆山)能源发展股份有限公司
公司是清华大学南策文院士团队领衔创办的高新技术企业,是国内固态锂电池产业化的领跑者。
http://www.jsqingtao.com/
上海芯旺微电子技术有限公司
基于自主研发的 KungFu指令集和内核架构,研发高性能数模混合信号MCU&DSP产品的芯片设计公司,同时向用户提供完整软硬件工具链系统,实现了从MCU芯片到基础软件生态的全覆盖。
https://www.chipon-ic.com/AboutUs/Index
江苏通行宝智慧交通科技股份有限公司
全国领先的为高速公路、干线公路以及城市交通等提供智慧交通平台化解决方案的国家高新技术企业
股票代码:301339.SZ
www.jstxb.com
亚信安全科技股份有限公司
中国网络安全软件领域的领跑者
股票代码:688225.SH
https://www.asiainfo-sec.com/
山东帅克宠物用品股份有限公司
集干粮、罐头、湿粮包、猫条、火腿肠、冻干、烘干等产品为一体的宠物食品全产业链供应专家
http://www.seekpet.net/
爱博诺德(北京)医疗科技股份有限公司
爱博诺德(北京)医疗科技股份有限公司,科创板上市企业,位于北京中关村国家自主创新示范区,是国家级高新技术企业、国家级专精特新“小巨人”企业。公司专注于眼科医疗器械的自主研发、生产、销售及相关服务。
股票代码:688050.SH
http://www.ebmedical.com/about/#profile
江苏亚虹医药科技股份有限公司
是一家专注于泌尿生殖系统肿瘤及其它重大疾病领域的全球化创新药公司。
股票代码:688176.SH
www.asieris.cn
德美联合(重庆)医疗科技有限公司
德美联合(重庆)医疗科技有限公司(简称“德美医疗”)是一家集运动医学植入物、手术工具、关节镜设备、运动康复器具和设备的研发、生产、销售、服务于一体的国际化医疗科技集团。
http://www.deltamedical.cn/

News

--MORE >
恒旭资本荣获融中2022-2023年度中国产业投资榜单多A项大奖
近日,由融资中国主办的“第九届产业投资峰会”在北京隆重举办。会上隆重发布了2022-2023年度中国产业投资榜。恒旭资本荣获“2022-2023年度中国新能源领域最佳投资机构”、“2022-2023年度中国智能网联汽车领域最佳投资机构”、“2022-2023年度中国集成电路与半导体领域卓越投资机构”,恒旭资本董事长陆永涛先生荣获“2022-2023年度中国新能源领域最佳投资人物”,这也是恒旭资本连
2023年6月企业动态
恒旭资本带您回顾2023年6月企业动态
恒旭资本荣获母基金周刊2023投资机构软实力「GP TOP10」及「新能源 TOP20」
恒旭资本荣获母基金周刊2023投资机构软实力「GP TOP10」及「新能源 TOP20」

Company advantages

  • Exceptional industrial background High-quality projects spun-off from the SAIC Providing environment for business realization Large customer base
  • Abundant and pragmatic resources Years resource accumulation in the industry Diverse and abundant investor resources Close relationship with intermediary and exchange
  • Long-term dedicated and professional team Our core team has been working together over ten years Top level professionals from first-class institutions Self-driven, diligent and responsible attitude
  • Efficient and compliant execution capabilities Efficient collaboration brought by market-oriented mechanisms Compliance awareness brought by state-owned company background Mature system honed over years of experience
Top

Statement:

It has been discovered that some entities or individuals maliciously impersonate our company and our employees, and conduct illegal financing through live broadcasts on the internet to profit illegally. Such illegal behavior has seriously damaged our image. We kindly remind you not to believe in information released other than our official channels, official channels of Hengxu Capital include - website: www.hengxucapital.com; WeChat account: Hengxu Capital (ID: Hengxucapital). Our solemn statement:

 

1.Illegal behavior carried out by anyone who impersonates our company or our employees will be subject to legal action and take legal responsibility for rights infringement, we pursue protecting the legitimate rights and interests of our company and our personnel. Hengxu Capital will not tolerate such illegal activities, we have taken and will continue to take legal action to pursue the legal responsibility of individuals or entities engaged in such illegal activities.

 

2.Hengxu Capital is a private equity and venture capital fund manager registered with Asset Management Association of China, and conducts business strictly in accordance with relevant regulatory requirements. To avoid losses, we would like to remind investors to be vigilant and invest through legal and legitimate channels, and not believe in false information obtained from non-official channels of Hengxu Capital.

 

3.Thank you for your kind support and attention. If you find any abnormal identity or information, please contact us for verification in a timely manner. At the same time, we encourage you to actively provide information and report aforementioned illegal activities at +86-21-22016849. Victim is requested to report to local police promptly to protect your own interests, and  ensure offenders are held accountable as soon as possible.

 

Shanghai SAIC Hengxu Capital Co., Ltd.

Aug. 22, 2022